Literature DB >> 11130376

Why should hepatitis C affect immune reconstitution in HIV-1-infected patients?

C S Graham1, M J Koziel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11130376     DOI： 10.1016/S0140-6736(00)03251-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.

Authors:  Estibaliz Lazaro; Gaelle Coureau; Jérémie Guedj; Patrick Blanco; Isabelle Pellegrin; Daniel Commenges; François Dabis; Jean-François Moreau; Jean-Luc Pellegrin; Rodolphe Thiébaut
Journal:  Antivir Ther       Date:  2006

2.  Hepatitis C and HIV-1 coinfection.

Authors:  A H Mohsen; P Easterbrook; C B Taylor; S Norris
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 3.  MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.

Authors:  Archana Gupta; Gokul Swaminathan; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  Viruses       Date:  2012-10-26       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.